St. Jude Medical Receives FDA Approval for the World’s Smallest Upgradeable MR-Conditional Spinal Cord Stimulation System

Go back to St. Jude Medical Receives FDA Approval for the World’s Smallest Upgradeable MR-Conditional Spinal Cord Stimulation System

St. Jude Medical (STJ) Announces Completion of Spinal Modulation Acquisition

May 4, 2015 9:13 AM EDT

St. Jude Medical (NYSE: STJ) has completed the acquisition of Spinal Modulation, Inc., developer of the Axium Neurostimulator System. The acquisition was completed on May 1, 2015.

With the closing of the acquisition, St. Jude Medical has become the only medical device manufacturer in the world to offer radiofrequency ablation (RFA), spinal cord... More

St. Jude Medical (STJ) Protégé MRI System Receives FDA Approval

April 30, 2015 9:08 AM EDT

St. Jude Medical (NYSE: STJ) announced FDA approval of the companys Protégé MRI spinal cord stimulation system. In addition to the approval of the new Protégé MRI system, St. Jude Medical has also secured FDA approval for MRI compatibility of the companys 60cm Octrode percutaneous leads, which has received MR-conditional labeling for use with the Protégé MRI system.

The Protégé MRI system is the smallest MR-conditional SCS implantable pulse generator (IPG) available in the United States, and the only upgradeable IPG on the market to allow patients to safely... More